CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 201 7 Added 20,566 New Subscribers in 4Q17 4Q17 Revenue Amounted to RMB202.0 Million ($29.3 Million) 4Q17 Operating Income Amounted to RMB56.3 Million ($8.2 Million) Conference Call to be Held on Ju]

By | 2017-06-22T02:16:47+00:00 June 21st, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Reports Financial Results for

[China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 201 7 Added 20,566 New Subscribers in 4Q17 4Q17 Revenue Amounted to RMB202.0 Million ($29.3 Million) 4Q17 Operating Income Amounted to RMB56.3 Million ($8.2 Million) Conference Call to be Held on Ju]

By | 2017-06-22T02:16:57+00:00 June 21st, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding “Going Private” Proposal HONG KONG, China, April 13, 2017 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoiet]

By | 2017-04-14T03:17:26+00:00 April 13th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Termination of Evaluation

[China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding “Going Private” Proposal HONG KONG, China, April 13, 2017 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoiet]

By | 2017-04-14T03:17:49+00:00 April 13th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: (Original Filing)

[April 13, 2017 The Board of Directors 48/F., Bank of China Tower, 1 Garden Road, Central, Hong Kong Non-binding Acquisition Proposal dated April 27, 2015 Re: Ladies and Gentlemen: Reference is made to above-described non-binding proposal. In view of the developments regarding Golden Meditech Holding]

By | 2017-04-14T03:16:19+00:00 April 13th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: April 13, 2017 The Board of Directors 48/F.,

[April 13, 2017 The Board of Directors 48/F., Bank of China Tower, 1 Garden Road, Central, Hong Kong Non-binding Acquisition Proposal dated April 27, 2015 Re: Ladies and Gentlemen: Reference is made to above-described non-binding proposal. In view of the developments regarding Golden Meditech Holding]

By | 2017-04-14T03:16:45+00:00 April 13th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Receives Notification of HONG KONG, China, April 6, 2017 - China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today a]

By | 2017-04-08T03:19:32+00:00 April 7th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Receives Notification of HONG

[China Cord Blood Corporation Receives Notification of HONG KONG, China, April 6, 2017 - China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today a]

By | 2017-04-08T03:20:06+00:00 April 7th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar